[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

HRP20020108A2 - Hydrodynamically balancing oral drug delivery system - Google Patents

Hydrodynamically balancing oral drug delivery system

Info

Publication number
HRP20020108A2
HRP20020108A2 HR20020108A HRP20020108A HRP20020108A2 HR P20020108 A2 HRP20020108 A2 HR P20020108A2 HR 20020108 A HR20020108 A HR 20020108A HR P20020108 A HRP20020108 A HR P20020108A HR P20020108 A2 HRP20020108 A2 HR P20020108A2
Authority
HR
Croatia
Prior art keywords
hydrodynamically
delivery system
drug delivery
oral drug
balancing
Prior art date
Application number
HR20020108A
Inventor
Naresh Talwar
John N Staniforth
Michael J Tobyn
Original Assignee
Ranbaxy Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ranbaxy Lab Ltd filed Critical Ranbaxy Lab Ltd
Publication of HRP20020108A2 publication Critical patent/HRP20020108A2/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0002Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007Effervescent

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HR20020108A 1999-08-04 2000-08-01 Hydrodynamically balancing oral drug delivery system HRP20020108A2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IB1999/001386 WO2001010405A1 (en) 1999-08-04 1999-08-04 Hydrodynamically balanced oral drug delivery system

Publications (1)

Publication Number Publication Date
HRP20020108A2 true HRP20020108A2 (en) 2003-12-31

Family

ID=11004886

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20020108A HRP20020108A2 (en) 1999-08-04 2000-08-01 Hydrodynamically balancing oral drug delivery system

Country Status (21)

Country Link
EP (1) EP1206249A4 (en)
JP (1) JP2003506400A (en)
CN (1) CN1376059A (en)
AP (1) AP2002002410A0 (en)
AU (2) AU5060499A (en)
BR (1) BR0012981A (en)
CA (1) CA2378468A1 (en)
CZ (1) CZ2002415A3 (en)
EA (1) EA200200126A1 (en)
HK (1) HK1047226A1 (en)
HR (1) HRP20020108A2 (en)
HU (1) HUP0202497A3 (en)
IL (1) IL147966A0 (en)
MX (1) MXPA02001272A (en)
NZ (1) NZ516959A (en)
OA (1) OA12003A (en)
PL (1) PL353321A1 (en)
SK (1) SK1832002A3 (en)
TR (1) TR200200467T2 (en)
WO (2) WO2001010405A1 (en)
ZA (1) ZA200200926B (en)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100457458B1 (en) * 2001-04-02 2004-11-17 삼아약품 주식회사 Rapidly dissolving tablet and process for preparing same
US7776345B2 (en) 2001-07-04 2010-08-17 Sun Pharma Advanced Research Company Ltd Gastric retention controlled drug delivery system
WO2003037296A2 (en) * 2001-10-29 2003-05-08 Labopharm Inc. Methods and dosage forms for improving the bioavailability of therapeutic agents
US20050226926A1 (en) 2002-07-25 2005-10-13 Pfizer Inc Sustained-release tablet composition of pramipexole
WO2005020879A2 (en) * 2003-08-27 2005-03-10 Vecta Ltd. Compositions for treating pathologies that necessitate suppression of gastric acid secretion
TW200533391A (en) * 2004-03-25 2005-10-16 Sun Pharmaceutical Ind Ltd Gastric retention drug delivery system
MXPA06015095A (en) * 2004-06-28 2007-07-17 Solvay Pharm Bv Oral sustained release formulation of tedisamil with gastric retention properties.
CN101884626A (en) 2004-08-13 2010-11-17 贝林格尔.英格海姆国际有限公司 Extended-release tablet comprising pramipexole or a pharmaceutically acceptable salt thereof, its preparation method and use
DE102004042139B4 (en) * 2004-08-31 2009-06-10 Aristocon Verwaltungs- Gmbh Peroral dosage forms to achieve a retarding effect after drug intake with a meal
EP1690540A1 (en) * 2005-02-15 2006-08-16 Neuro3D Composition comprising ocaperidone
ES2643140T3 (en) 2005-12-22 2017-11-21 Oakwood Laboratories L.L.C. Sublimable slow release delivery system and procedure for carrying it out
EP1886665A1 (en) * 2006-08-01 2008-02-13 Boehringer Ingelheim Pharma GmbH & Co. KG Gastro retentive delivery system
ATE476176T1 (en) 2007-03-02 2010-08-15 Farnam Co Inc SUSTAINED-RELEASE TABLETS CONTAINING WAX-LIKE MATERIAL
BRPI0917444A2 (en) 2008-08-15 2015-12-01 Depomed Inc gastric retention pharmaceutical compositions for the treatment and prevention of snc diseases
EP2329810A4 (en) 2008-08-18 2012-09-19 Team Academy Of Pharmaceutical Science Gastric retention drug delivery system, preparation method and use thereof
AP2011005687A0 (en) 2008-10-08 2011-06-30 Bioplus Life Sciences Pvt Ltd Sustained release drug delivery system.
EP2283824B1 (en) 2009-07-30 2017-04-19 Special Products Line S.p.A. Compositions and formulations based on swellable matrices for sustained release of poorly soluble drugs such as clarithromycin
JP2013103879A (en) * 2011-11-10 2013-05-30 Nakanihon Capsule Co Ltd Hard capsule
KR102241487B1 (en) 2013-02-20 2021-04-16 주식회사 종근당 Pharmaceutical composition consisting of sustained-release pellets
MX365914B (en) * 2013-03-15 2019-06-20 Aprecia Pharmaceuticals LLC Rapidly dispersible dosage form of topiramate.
CN103462917A (en) * 2013-09-12 2013-12-25 南京正宽医药科技有限公司 Antiviral acyclovir tablet and preparation method thereof
CA3027896C (en) * 2016-06-14 2021-07-13 Prevtec Microbia Inc. Animal feed pellets including a feed additive, method of making and of using same
US10987311B2 (en) 2017-06-16 2021-04-27 Kashiv Specialty Pharmaceuticals, Llc Extended release compositions comprising pyridostigmine
EP3648747B1 (en) 2017-06-16 2022-09-07 Amneal Complex Products Research LLC Gastroretentive dosage forms for sustained drug delivery
US10588863B2 (en) 2017-06-16 2020-03-17 Kashiv Biosciences, Llc Extended release compositions comprising pyridostigmine
CN107375287B (en) * 2017-08-22 2019-11-29 安徽省肿瘤医院 A kind of purposes of atropine sulfate in preparation treatment Primary Hepatic cancer drug
CN107441115A (en) * 2017-08-22 2017-12-08 安徽省肿瘤医院 A kind of purposes of Verapamil joint sodium acid carbonate in primary liver cancer medicine is prepared
CN107349195A (en) * 2017-08-22 2017-11-17 安徽省肿瘤医院 A kind of Verapamil is preparing the purposes in treating metastatic hepatic carcinoma medicine
WO2019246145A1 (en) 2018-06-18 2019-12-26 Kashiv Biosciences, Llc Extended release compositions comprising pyridostigmine
WO2020006278A1 (en) * 2018-06-27 2020-01-02 Kashiv Biosciences, Llc Self-regulating osmotic gastroretentive drug delivery systems
WO2020230089A1 (en) 2019-05-14 2020-11-19 Clexio Biosciences Ltd. Treatment of nocturnal symptoms and morning akinesia in subjects with parkinson's disease
WO2022195476A1 (en) 2021-03-15 2022-09-22 Clexio Biosciences Ltd. Gastroretentive devices for assessment of intragastric conditions

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH675537A5 (en) * 1988-03-25 1990-10-15 Ciba Geigy Ag
US5096714A (en) * 1988-06-28 1992-03-17 Hauser-Kuhrts, Inc. Prolonged release drug tablet formulations
WO1991006281A1 (en) * 1989-10-26 1991-05-16 Nippon Shinyaku Co., Ltd. Gastric preparation
MX9300110A (en) * 1992-01-13 1994-07-29 Gerhard Gergely PHARMACEUTICAL PREPARATION IN THE FORM OF AN EFFERVESCENCE OR DISINTEGRATION TABLET OR OF AN INSTANT-TYPE GRANULATE AND PROCEDURE FOR ITS PREPARATION.
GB9322314D0 (en) * 1993-10-29 1993-12-15 Scherer Ltd R P Foam generating capsules
DE4403943A1 (en) * 1994-02-08 1995-08-10 Hexal Pharma Gmbh Oral preparation of the preparation with diclofenac sodium
GB9418530D0 (en) * 1994-09-14 1994-11-02 Glaxo Group Ltd Medicaments
US5788987A (en) * 1997-01-29 1998-08-04 Poli Industria Chimica Spa Methods for treating early morning pathologies
IT1293764B1 (en) * 1997-07-23 1999-03-10 Chiesi Farma Spa PHARMACEUTICAL COMPOSITIONS IN THE FORM OF EFFERVESCENT TABLETS CONTAINING AN UNSTABLE ACTIVE IN THE PRESENCE OF WATER

Also Published As

Publication number Publication date
EA200200126A1 (en) 2002-10-31
PL353321A1 (en) 2003-11-17
OA12003A (en) 2006-04-18
AP2002002410A0 (en) 2002-03-31
EP1206249A4 (en) 2004-12-22
AU5060499A (en) 2001-03-05
HUP0202497A2 (en) 2002-11-28
CA2378468A1 (en) 2001-02-15
SK1832002A3 (en) 2002-08-06
AU6309900A (en) 2001-03-05
WO2001010405A1 (en) 2001-02-15
EP1206249A1 (en) 2002-05-22
CZ2002415A3 (en) 2002-08-14
HUP0202497A3 (en) 2004-05-28
NZ516959A (en) 2003-10-31
IL147966A0 (en) 2002-09-12
AU774957B2 (en) 2004-07-15
WO2001010419A1 (en) 2001-02-15
JP2003506400A (en) 2003-02-18
ZA200200926B (en) 2002-11-27
CN1376059A (en) 2002-10-23
BR0012981A (en) 2002-06-18
HK1047226A1 (en) 2003-02-14
MXPA02001272A (en) 2002-07-22
TR200200467T2 (en) 2002-08-21

Similar Documents

Publication Publication Date Title
HRP20020108A2 (en) Hydrodynamically balancing oral drug delivery system
GB9904629D0 (en) Oral drug delivery system
PL355263A1 (en) Drug delivery device
AU7333601A (en) Drug delivery management system
AU2123200A (en) Drug delivery device
AU4985600A (en) Drug delivery device
AU2002302890A1 (en) Hydrodynamically balancing oral drug delivery system with biphasic release
EP1061987A4 (en) Drug delivery system
AU4947100A (en) Drug delivery device
AU3520900A (en) Implantable drug delivery system
EP1087753A4 (en) Targeted liposomal drug delivery system
EP0989878A4 (en) Drug delivery system
EP1021137A4 (en) Drug delivery system
GB2352314B (en) Delivery system
GB0011066D0 (en) Delivery system
GB0029843D0 (en) Drug delivery system
GB9930160D0 (en) Drug delivery
GB9914960D0 (en) Delivery system
AU2002210580A1 (en) Drug delivery system
GB9901133D0 (en) Drug delivery system
GB9902509D0 (en) Drug delivery system
GB9923273D0 (en) Medicament delivery system
GB9905134D0 (en) Medicament delivery system
GB9917470D0 (en) Medicament delivery system
GB9800835D0 (en) Drug delivery system

Legal Events

Date Code Title Description
A1OB Publication of a patent application
AIPI Request for the grant of a patent on the basis of a substantive examination of a patent application
ODBI Application refused